Skye Hsin-Hsien Yeh1,2, Chi-Wei Chang3, Tsung-Hsun Yu1,2, Wen-Sheng Huang4 1School of Medicine, National Defense Medical Center, Taipei, Taiwan 2Brain Research Center, National Yang Ming Chaio Tung University, Taipei, Taiwan 3Primo Biotechnology, Taipei, Taiwan 4Department of Nuclear Medicine, Cheng Hsin General Hospital, Taipei, Taiwan This study poster was presented at the 34th Annual Meeting of the…

Ya-Ting Huang, RN, NP, PhD, Li-Yu Chen, MS, Chih-Yi Wu, BD, Ya-Yao Huang, PhD, Yuh-Feng Wang, MD, PhD Posted by the 2022 Annual Conference of SNM, Taiwan Introduction The incidence of prostate cancer is fourth place in the world, but the diagnostic tools for early detected prostatic cancer have limitations due to poor diagnostic performance….

Chih-Yi Wu, BS, Li-Yu Chen, MS, Ya-Ting Huang, RN, NP, PhD, Ya-Yao Huang, PhD Posted by 2022 Annual Conference of SNM, Taiwan Introduction 67Ga-Citrate is routinely used for inflammation scan with scintillation camera in Taiwan. Typically, patients receive 4~6 mCi of 67Ga-Citrate injection and then the scan will be performed at 48 hours post administration….

Dr. Chi-Wei Chang, a highly-experienced radiochemist in the field of radiopharmaceuticals in Taiwan, has been dedicated in the field of positron radiopharmaceutical synthesis for more than 30 years and had received a Ph. D of the department of Biomedical Imaging and Radiological Sciences in National Yang-Ming University (it’s now renamed as National Yang-Ming Chiao-Tung University)…

Primo Biotechnology aims to provide precision medicine and benefit the cancer patient. We decided to launch the Tackle Cancer Challenge – Radiotheranostics on the move with the Oncidium foundation : a campaign encouraging everyone to exercise together to reach the goal of 5000 kilometers and to help to increase awareness about radiotheranostics in cancer care….

Ya-Ting Huang PhD, Neng-Chuan Tseng MD, Yen-Kung ChenMD, Kuo-How Huang MD, Hsiu-Ying Lin RN, Ya-Yao Huang PhD, Thomas I.S. Hwang MD, Yen-Chuan Ou MD Published by Clinical Nuclear Medicine 47(9):p 755-762, September 2022 Abstract Background Multiple tools are now available to determine the requirement for a biopsy to diagnose prostate cancer, and PET/CT with radiolabeled…

In order to speed the development of precision medicine and benefit the cancer patient, the Belgium based nonprofit organization Oncidium is established since 2011. Oncidium takes the mission to support and accelerate the growth and the use of novel radiopharmaceuticals for cancer treatment, without the concern of source, skills and finance status. Oncidium is dedicated…